NewsBenzingaOKYOファーマ、神経障害性角膜痛に対するウルコシモドの第3相NEPTUNE試験で最初の患者登録を発表 OKYOファーマ、神経障害性角膜痛に対するウルコシモドの第3相NEPTUNE試験で最初の患者登録を発表 Benzinga 2026.10.06 11:05 (GMT+0) Open on Benzinga Other news How to Play CSCO Stock as Cisco Bets on Sovereign AI CoStar Group's Quarterly Earnings Preview: What You Need to Know Pinterest’s AI now turns beauty Pins into action plans Uber is spending $2.3B to get into catering US CFTC's latest ANPRM seeks to use existing authority to build a crypto spot market framework Get all your questions answered at TechCrunch Disrupt 2026: The full breakout session agenda revealed
Get all your questions answered at TechCrunch Disrupt 2026: The full breakout session agenda revealed
